Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: null- ASA1/2
Conditions
Interventions
Intervention1: dexmedetomidine: patients in this group will receive TAP block on each side with 0.375% ropivacaine 20 ml along with 0.5 mcg/kg dexmedetomidine as additive
Control Intervention1: PLAIN
Sponsors
SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients undergoing elective abdominal hysterectomy 2 ASA 1 /2 3 Those are willing participate
Exclusion criteria
Exclusion criteria: 1 Patient refusal 2 Patients with ASA III and IV 3 Patients with BMI 40 kg/m2 4 Local infection at the site of block 5 Allergy to study medications 6 Chronic use of pain medications or adrenoreceptor agonists or antagonists
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare analgesic effect of dexmedetomidine added to ropivacaine in TAP block vs dexmedetomidine given intravenously at the time of TAP block. Timepoint: Assesed pain score immediately after block 15min, 30min,45min,60min,120min,4hrs 8 hr,12 hr 24hr | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the total duration of analgesia 2. To determine number of rescue analgesics used in 24 h 3. To determine VAS scores in first 24 h 4. To assess side effects of dexmedetomidine, if any Timepoint: 24HOURS | — |
Countries
India
Contacts
Public ContactRavi bhat
SDM COLLEGE OF MEDICAL SCEINCES AND HOSPITAL
Outcome results
None listed